CCRN: 15-12G/A · other
Cross Country Healthcare filed an amendment to its Form 15, correcting an administrative error to establish July 31, 2026, as the effective date for terminating the registration of its common stock. The company is suspending its duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The certification indicates that the company currently has approximately one holder of record. This reduction below the threshold required for public reporting allows the company to deregister its securities and cease public disclosure obligations. This filing signals that Cross Country Healthcare has effectively transitioned to private status or has been acquired, resulting in the end of its life as a publicly traded entity.
CCRN: 8-K · acquisition merger
Cross Country Healthcare, Inc. has completed its merger with KL Criss Cross Intermediate, LLC, an affiliate of Knox Lane, in a transaction valued at $13.25 per share in cash. Effective July 21, 2026, the company has become a wholly-owned subsidiary of Parent and will operate as a privately held entity. As a result of the merger, the company requested that Nasdaq suspend trading and remove its common stock from listing, which occurred on July 21, 2026. The company intends to file a Form 15 to terminate its registration and suspend reporting obligations under the Exchange Act. All incumbent directors, including Chairman and CEO Kevin C. Clark, have resigned from the board, with Joel Tremblay appointed as the new Chief Executive Officer. Concurrently, the company discharged all obligations under its ABL Credit Agreement with Wells Fargo Bank.
CCRN: 15-12G · other
Cross Country Healthcare, Inc. has filed a Form 15 to terminate its registration under Section 12(g) of the Securities Exchange Act of 1934. The company cited having fewer than 300 holders of record, specifically noting approximately one holder of record, as the basis for suspending its reporting obligations. As a result of this filing, the company is suspending its duty to file reports under Sections 13 and 15(d) of the Exchange Act. Cross Country Healthcare will no longer be required to submit periodic reports, financial statements, or other disclosures to the SEC. This action effectively marks the end of the company's status as a public reporting entity, often occurring when a company is taken private or its shareholder base drops below the threshold requiring public disclosure.
Cross Country Healthcare Clears Key Hurdle as Stockholders Approve Merger
Cross Country Healthcare, Inc. shareholders have approved the Agreement and Plan of Merger with KL Criss Cross Intermediate, LLC, authorizing the company to be taken private. The merger proposal received overwhelming support with 23,356,105 shares voted in favor compared to only 12,309 against, constituting approximately 72.36% of the total outstanding shares represented at the special meeting. Subject to customary closing conditions, the transaction is expected to close in the third quarter of 2026, after which the company's common stock will be delisted from the NASDAQ Stock Market and deregistered.
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired on June 22, 2026, regarding the pending merger of Cross Country Healthcare, Inc. and the sale of the company's locums business division. This expiration satisfies a major condition to the closing of the transactions, which remain subject to other customary conditions. The merger is expected to close in the third quarter of calendar year 2026. A special meeting of shareholders to approve the merger is scheduled for July 16, 2026, at 12:00 p.m. Eastern Time.
CCRN: DEFM14A · acquisition merger
Cross Country Healthcare, Inc. has entered into a definitive agreement to be acquired by KL Criss Cross Intermediate, LLC, an affiliate of Knox Lane LP. Shareholders will receive $13.25 in cash for each share held, representing a 31% premium to the closing price on May 6, 2026, and a 45% premium to the 90-day volume-weighted average price. The transaction values the company at approximately $428 million based on outstanding shares. The Cross Country Board of Directors unanimously approved the merger agreement and recommends that stockholders vote in favor of the proposal at the special meeting scheduled for July 16, 2026. BofA Securities issued a written opinion concluding that the merger consideration is fair from a financial point of view to the company’s stockholders. Completion of the merger is expected in the third quarter of 2026, subject to stockholder approval and regulatory clearances. If the merger is completed, Cross Country common stock will be delisted from the Nasdaq Global Select Market and deregistered, and the company will become a wholly-owned subsidiary of Parent. The proxy statement includes three proposals for the special meeting: the adoption of the merger agreement, an advisory vote on executive compensation related to the merger, and a proposal to adjourn the meeting if necessary to solicit additional proxies.
CCRN: PREM14A · acquisition merger
Cross Country Healthcare, Inc. (CCRN) has entered into a definitive agreement to be acquired by KL Criss Cross Intermediate, LLC, a subsidiary of investment firm Knox Lane, for $13.25 per share in cash. The transaction represents an approximately 31% premium to the closing price on May 6, 2026, and a 45% premium to the 90-day volume-weighted average price. The Cross Country board of directors unanimously approved the merger and recommends that stockholders vote in favor of the proposal at the upcoming special meeting. Upon completion, Cross Country will become a wholly-owned subsidiary of Parent, cease to be a publicly traded company, and be delisted from Nasdaq. The merger is subject to customary closing conditions, including stockholder approval and the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period, which is expected to expire on June 22, 2026. The parties expect to complete the merger in the third quarter of 2026.
Cross Country Expands AI-Powered Workforce Intelligence for Health Systems Through Exclusive Optimé Solution
Cross Country Healthcare has entered into an exclusive 36-month partnership to integrate the Optimé workforce strategy and planning solution into its Intellify® platform. Optimé adds advanced forecasting, analytics, and workforce optimization capabilities to Intellify, helping health systems better align workforce supply with patient demand and reduce labor costs. The partnership is part of Cross Country's broader strategy to evolve from a workforce solutions provider to a technology-enabled workforce partner, enhancing its ability to help health systems manage workforce complexity more efficiently.
Cross Country Healthcare (CCRN) Reports Q1 Loss, Beats Revenue Estimates
Here's What Key Metrics Tell Us About Cross Country (CCRN) Q1 Earnings
Cross Country Healthcare Announces First Quarter 2026 Financial Results
Cross Country Healthcare reported a Q1 2026 net loss of $4.266 million and a net loss per share of $0.14, indicating a bearish sentiment. The company announced a merger with KL Criss Cross Intermediate, LLC, which is expected to close in the third quarter of 2026. This merger could have a bullish impact on the company's future operations and growth. Cross Country Healthcare also repurchased over 650,000 shares for $5.8 million, which is a positive sign for the company's financial health. The company ended the quarter with $105.584 million in cash and no debt, showing a strong financial position despite the net loss. The merger with KL Criss Cross Intermediate, LLC is expected to provide the company with new opportunities for growth and expansion in the healthcare staffing industry.
Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million
Cross Country Healthcare and Florida Atlantic University’s Christine E. Lynn College of Nursing Release Purpose Under Pressure: The State of Nursing in 2026
Cross Country Healthcare and Florida Atlantic University released their fifth annual nursing survey, Purpose Under Pressure: The State of Nursing in 2026. The study, based on insights from more than 2,000 nurses and students, indicates that while 99% of nursing students are optimistic, industry pressures have intensified with burnout rising to 67% and pay concerns more than doubling since 2022. CCRN positions the findings as a roadmap for healthcare leaders to improve flexibility and retention, aligning with its tech-enabled workforce solutions.
Cross Country Healthcare Marks 40 Years, Accelerates Next Generation of Workforce Intelligence and Orchestration
Cross Country Healthcare is celebrating its 40th anniversary by accelerating investments in workforce intelligence and embedded AI across its contingent workforce operations. The company is expanding its proprietary Intellify platform into adjacent high-growth markets like locums and home-based care to provide better forecasting and cost optimization. CEO Kevin Clark emphasized that the company's deep clinical history differentiates its AI capabilities from technology-first competitors.
Cross Country Appoints Darrick Sogabe as Chief Product Officer, Advancing the Company’s Growing Technology Portfolio
Cross Country Healthcare appointed Darrick Sogabe as Chief Product Officer to advance its technology portfolio and accelerate workforce strategy. As the architect of the company's flagship Intellify platform, Sogabe brings over 20 years of experience to lead the next phase of product innovation and enterprise growth. His focus includes integrating contingent labor, compliance, and analytics with agentic AI to help health systems improve decision-making and cost efficiency.
Cross Country Appoints Chris Tyrell as Chief Information Officer to Support Next Phase of Enterprise AI and Platform Strategy
Cross Country Healthcare appointed Chris Tyrell as Chief Information Officer to advance its enterprise AI, automation, and platform strategy. Tyrell joins with over 20 years of experience, most recently as CTO at Eclipse Advantage, and will focus on scaling the Intellify platform and modernizing infrastructure. CEO Kevin Clark emphasized that the technology investment is intended to serve as a growth lever and competitive advantage.
Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
